**Core Concept:** Insulin therapy forms an integral part of diabetes management, particularly for patients with type 1 diabetes and some with type 2 diabetes. Insulin is a hormone produced by the pancreas that regulates glucose levels in the blood by facilitating glucose uptake into cells.

**Why the Correct Answer is Right:** Insulin therapy is used in diabetes management as it helps to lower blood glucose levels, preventing complications related to hyperglycemia. The correct answer, "B. Regular insulin," is a rapid-acting insulin analogue that starts working within 15 minutes and reaches peak effect in about 30-90 minutes after injection. Regular insulin is commonly used for mealtime insulin injections in patients with type 1 diabetes and some patients with type 2 diabetes.

**Why Each Wrong Option is Incorrect:**

A. Intermediate insulin (C. Isophane insulin): This is a long-acting insulin analogue that starts working in 2-4 hours and reaches peak effect in 6-12 hours. It is typically used for basal insulin injections in patients with type 1 diabetes and some patients with type 2 diabetes.

D. Long-acting insulin (long-acting insulin analogue): These insulin types are not mentioned in the options, but they include insulin detemir (Levemir) and insulin glargine (Lantus). These insulin types are used for basal insulin injections in patients with type 1 and type 2 diabetes.

C. Short-acting insulin (Aspart, lispro, or glulisine): These are rapid-acting insulin analogues, used for mealtime insulin injections. They provide a short duration of action (peak effect in 1-4 hours) and are not suitable for long-term management of blood glucose levels.

**Clinical Pearls:**

1. Insulin therapy should be tailored to the patient's specific needs, taking into account factors like mealtime, basal, and bolus insulin requirements.
2. Regular insulin is used for both mealtime and basal insulin requirements, but its duration of action is not suitable for long-term management of blood glucose levels.
3. Insulin analogues have a more predictable pharmacokinetic and pharmacodynamic profile compared to human insulin, making them more suitable for long-term diabetes management.

**Explanation:**

Insulin therapy aims to mimic the body's natural insulin production and response to food intake. Regular insulin works rapidly but has a short duration of action, making it unsuitable for long-term blood glucose management. In contrast, insulin analogues, such as aspart, lispro, and glulisine, have a more predictable pharmacokinetic and pharmacodynamic profile, allowing for better long-term blood glucose control.

**Why the Correct Answer is Right:** Regular insulin is a human insulin preparation, derived from pigs or cows, which has a rapid absorption and peak effect within 30-90 minutes, making it unsuitable for long-term blood glucose management. In contrast, insulin analogues are synthesized versions of regular insulin with altered amino acid sequences, resulting in slower absorption, a more predictable peak effect, and a longer duration of action. This makes